Methylenedioxymethamphetamine Induced Neuro-Psychiatric Disorders: A Case Report from Southern IndiaCorrespondence Address :
Dr. N.A. Uvais,
IQRAA International Hospital and Research Centre, Malaparamba, Calicut-673009, Kerala, India.
The recreational drug MDMA (3,4-methylenedioxymethamphetamine), which is a stimulant and hallucinogen, has become increasingly popular among the young population of both developed and developing world. We describe a case report of persistent neuropsychiatric disorders in a previously healthy, 21-year-old college student after a single ingestion of MDMA. We detail the psychiatric symptoms with syndromic diagnosis and treatment outcome. Furthermore, the paper describe changes in the demographics of the use of MDMA and discuss the public health challenges posed by the increasing popularity of recreational drugs in the Indian context.
Delirium, Depression, Psychosis
NA Uvais. METHYLENEDIOXYMETHAMPHETAMINE INDUCED NEURO-PSYCHIATRIC DISORDERS: A CASE REPORT FROM SOUTHERN INDIA. Journal of Clinical and Diagnostic Research [serial online] 2018 July [cited: 2019 Jan 19 ]; 12:VD01-VD02. Available from
Date of Submission: Dec 18, 2017
Date of Peer Review: Feb 01, 2018
Date of Acceptance: Apr 16, 2018
Date of Publishing: Jul 01, 2018
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2016: 132.37
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase & EMbiology
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)